title: Alternative ways of expressing forced expiratory volume in the first second and long-term mortality in elderly patients with asthma.
abstract: BACKGROUND
  Clinical and epidemiologic evidence on asthma in the elderly is scant. There is evidence that forced expiratory volume in the first second (FEV1), a commonly used indicator of overall pulmonary function, might not be an independent predictor of 5-year mortality in elderly patients with asthma.
  
  
  OBJECTIVE
  To investigate the association between FEV1 expressed using 3 alternative methods and 5-, 10-, and 15-year mortality in a population of elderly patients with asthma.
  
  
  METHODS
  Participants in the Salute Respiratoria nell' Anziano study were included. Asthma was diagnosed at baseline according to spirometric and clinical data. Vital status at 15 years was assessed using death registries. FEV1 was expressed as percentage of predicted, divided by height cubed, and as a multiple of the sex-specific first percentile. The association between FEV1 and mortality was evaluated using Cox proportional hazard models.
  
  
  RESULTS
  Two hundred patients were studied (52% women, mean age 73.1 years, standard deviation 6.2 years). All FEV1 measurements were associated with mortality at unadjusted analysis. After correction for potential confounders, no association was found between FEV1 and 5-year mortality. Only FEV1 as a multiple of the sex-specific first percentile was independently associated with 10-year (hazard ratio 0.35, 95% confidence interval 0.14-0.87) and 15-year (hazard ratio 0.38, 95% confidence interval 0.19-0.79) mortality.
  
  
  CONCLUSIONS
  Although extensively used, FEV1 expressed as percentage of predicted does not seem to be the best predictor of mortality in elderly patients with asthma. Although no spirometric index can predict 5-year mortality in this population, FEV1 as a multiple of the sex-specific first percentile should be considered when longer-term prognostic stratification is needed.
authors.affiliation: Unit of Geriatrics, Campus Biomedico University, Rome, Italy; Fondazione Alberto Sordi, Rome, Italy.
authors.forename: Claudio
authors.initials: C
authors.lastname: Pedone
authors.forename: Simone
authors.initials: S
authors.lastname: Scarlata
authors.forename: Anna
authors.initials: A
authors.lastname: Zito
authors.forename: Francesco
authors.initials: F
authors.lastname: Forastiere
authors.forename: Nicola
authors.initials: N
authors.lastname: Scichilone
authors.forename: Salvatore
authors.initials: S
authors.lastname: Battaglia
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Bellia
authors.forename: Raffaele
authors.initials: R
authors.lastname: Antonelli-Incalzi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001249:Asthma / Q000401:mortality* / Q000503:physiopathology*; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008297:Male; D011379:Prognosis; D012129:Respiratory Function Tests; D013147:Spirometry